Evidence map›Paper›PMID 22873495›Full record

ArticleCurrent drug safety2012

Ketamine induces toxicity in human neurons differentiated from embryonic stem cells via mitochondrial apoptosis pathway.

Zeljko J Bosnjak, Yasheng Yan, Scott Canfield, Maria Y Muravyeva, Chika Kikuchi, Clive W Wells, John A Corbett, Xiaowen Bai

Abstract read
In one paragraph

Article in Current drug safety, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 86 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. The Ketamine Antidepressant Story: New Insights.Molecules (Basel, Switzerland) · 2020
    Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Zeljko J BosnjakDepartment of Anesthesiology, The Medical College of Wisconsin, Milwaukee, 53226, USA.
Yasheng Yan
Scott Canfield
Maria Y Muravyeva
Chika Kikuchi
Clive W Wells
John A Corbett
Xiaowen Bai
Medical College of Wisconsin · US

Funding

Stem Cell CoreP01GM066730 · NIGMS · MEDICAL COLLEGE OF WISCONSIN · PI DASH, RANJAN K · 2003 to 2019
$23.6M
INTERACTION BETWEEN ANESTHETICS AND CALCIUM ANTAGONISTSR01HL034708 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI BOSNJAK, ZELJKO J. · 1986 to 2013
$3.9M
NHLBI NIH HHS R01 HL034708NHLBI NIH HHS R01HL034708NIGMS NIH HHS P01 GM066730NIGMS NIH HHS P01GM066730
6 · The paper itself

Abstract

Ketamine is widely used for anesthesia in pediatric patients. Growing evidence indicates that ketamine causes neurotoxicity in a variety of developing animal models. Our understanding of anesthesia neurotoxicity in humans is currently limited by difficulties in obtaining neurons and performing developmental toxicity studies in fetal and pediatric populations. It may be possible to overcome these challenges by obtaining neurons from human embryonic stem cells (hESCs) in vitro. hESCs are able to replicate indefinitely and differentiate into every cell type. In this study, we investigated the toxic effect of ketamine on neurons differentiated from hESCs. Two-week-old neurons were treated with different doses and durations of ketamine with or without the reactive oxygen species (ROS) scavenger, Trolox. Cell viability, ultrastructure, mitochondrial membrane potential (ΔΨm), cytochrome c distribution within cells, apoptosis, and ROS production were evaluated. Here we show that ketamine induced ultrastructural abnormalities and dose- and time-dependently caused cell death. In addition, ketamine decreased ΔΨm and increased cytochrome c release from mitochondria. Ketamine also increased ROS production and induced differential expression of oxidative stress-related genes. Specifically, abnormal ultrastructural and ΔΨm changes occurred earlier than cell death in the ketamine-induced toxicity process. Furthermore, Trolox significantly decreased ROS generation and attenuated cell death caused by ketamine in a dose-dependent manner. In conclusion, this study illustrates that ketamine time- and dose-dependently induces human neurotoxicity at supraclinical concentrations via ROS-mediated mitochondrial apoptosis pathway and that these side effects can be prevented by the antioxidant agent Trolox. Thus, hESC-derived neurons might provide a promising tool for studying anesthetic-induced developmental neurotoxicity and prevention strategies.

Indexed as

Anesthetics, DissociativeAntioxidantsApoptosisCell DifferentiationChromansCytochromes cDose-Response Relationship, DrugEmbryonic Stem CellsHumansIn Vitro TechniquesKetamineMembrane Potential, MitochondrialMitochondriaNeuronsNeurotoxicity SyndromesOxidative Stress6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acidAnesthetics, DissociativeAntioxidantsChromansCytochromes cKetamineReactive Oxygen Species

Identifiers

PMID22873495
PMCPMC3684944
OpenAlexW2121245461

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.